We set out to estimate net survival trends for 10 common cancers in 279 cancer registry populations in 67 countries around the world, as part of the CONCORD-2 study. Net survival can be interpreted as the proportion of cancer patients who survive up to a given time, after eliminating the impact of mortality from other causes (background mortality). Background mortality varies widely between populations and over time. It was therefore necessary to construct robust life tables that accurately reflected the background mortality in each of the registry populations. Life tables of all-cause mortality rates by single year of age and sex were constructed by calendar year for each population and, when possible, by racial or ethnic sub-groups. We us...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveilla...
SummaryBackgroundWorldwide data for cancer survival are scarce. We aimed to initiate worldwide surve...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillan...
BACKGROUND: We set out to estimate net survival trends for 10 common cancers in 279 cancer registry ...
BACKGROUND: The CONCORD study compares population-based relative survival from cancer using data fro...
Abstract BACKGROUND: The CONCORD study compares population-based relative survival from cancer using...
The CONCORD-2 study has initiated worldwide surveillance of population-based cancer survival, a metr...
The CONCORD study compares population-based relative survival from cancer using data from cancer reg...
Background: In 2015, the second cycle of the CONCORD programme established global surveillance of ca...
BACKGROUND In 2015, the second cycle of the CONCORD programme established global surveillance of ca...
In 2015, the second cycle of the CONCORD programme established global surveillance of cancer surviva...
Background In 2015, the second cycle of the CONCORD programme established global surveillance of can...
BACKGROUNDRobust comparisons of population-based cancer survival estimates require tight adherence t...
SummaryBackgroundCancer survival varies widely between countries. The CONCORD study provides surviva...
Background - Cancer survival varies widely between countries. The CONCORD study provides survival es...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveilla...
SummaryBackgroundWorldwide data for cancer survival are scarce. We aimed to initiate worldwide surve...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillan...
BACKGROUND: We set out to estimate net survival trends for 10 common cancers in 279 cancer registry ...
BACKGROUND: The CONCORD study compares population-based relative survival from cancer using data fro...
Abstract BACKGROUND: The CONCORD study compares population-based relative survival from cancer using...
The CONCORD-2 study has initiated worldwide surveillance of population-based cancer survival, a metr...
The CONCORD study compares population-based relative survival from cancer using data from cancer reg...
Background: In 2015, the second cycle of the CONCORD programme established global surveillance of ca...
BACKGROUND In 2015, the second cycle of the CONCORD programme established global surveillance of ca...
In 2015, the second cycle of the CONCORD programme established global surveillance of cancer surviva...
Background In 2015, the second cycle of the CONCORD programme established global surveillance of can...
BACKGROUNDRobust comparisons of population-based cancer survival estimates require tight adherence t...
SummaryBackgroundCancer survival varies widely between countries. The CONCORD study provides surviva...
Background - Cancer survival varies widely between countries. The CONCORD study provides survival es...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveilla...
SummaryBackgroundWorldwide data for cancer survival are scarce. We aimed to initiate worldwide surve...
BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillan...